|Age:||18 years or older|
|Type:||Drug study, Phase 4|
If you decide that you want to be in this study, the study doctor or member of the study staff will review with you all of the conditions that qualify or disqualify you from taking part in this study.
Before the start of treatment, you will participate in a “screening period”, when the study doctor will determine if you are able to enter the study.
You will receive one dose of study drug through an intravenous administration in a vein. You will receive the study drug within 24 hours of your hospital admission. Neither you nor the study doctor will choose what treatment you get.
You will be randomly put into a treatment group by chance to receive either: ● Magnesium Sulfate; or ● Normal Saline You will have a 50% (1 in 2) chance of receiving magnesium sulfate (study drug) and a 50% (1 in 2) chance of receiving normal saline (placebo).
Have any questions or want to learn more? Leave your contact details below and the research team will reach out to you.